Items where Author is "Nabavi, SM"

Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Penson, PE, Bruckert, E, Marais, D, Reiner, Ž, Pirro, M, Sahebkar, A, Bajraktari, G, Mirrakhimov, E, Rizzo, M, Mikhailidis, DP, Sachinidis, A, Gaita, D, Latkovskis, G, Mazidi, M, Toth, PP, Pella, D, Alnouri, F, Postadzhiyan, A, Yeh, H, Mancini, GBJ et al (2022) Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP). Journal of Cachexia, Sarcopenia and Muscle. ISSN 2190-5991

Cybulska, B, Kłosiewicz-Latoszek, L, Penson, PE, Nabavi, SM, Lavie, CJ, Banach, M and International Lipid Expert Panel (ILEP) (2020) How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors. Progress in Cardiovascular Diseases. ISSN 0033-0620

Banach, M, Penson, P, Fras, Z, Vrablik, M, Pella, D, Reiner, Z, Nabavi, SM, Sahebkar, A, Kayikcioglu, M, Daccord, M, FH Europe and International Lipid Expert Panel (ILEP) (2020) Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacological Research, 158. ISSN 1043-6618

This list was generated on Fri May 16 14:32:33 2025 UTC.